Michael Demurjian is the founder of Aspargo Laboratories. Aspargo Laboratories has raised $60M in total funding. Latest round: Growth. Based in New York, NY.
Michael Demurjian is the Founder and Chairman & CEO of Aspargo Laboratories, a commercial-stage specialty pharmaceutical and med-tech company. The company focuses on oral liquid suspension drug delivery systems, developing proprietary formulations of prescription and over-the-counter medications.
Full founder directory · Investor directory · Company funding database · Fundraising library